Camps-Vilaro, A, Perez-Fernandez, S, Subirana, I, Teira, R, Estrada, V, Domingo, P, Degano, IR, Marrugat, J. Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population. Journal of Personalized Medicine. 2021; 11(11)DOI:10.3390/jpm11111085. PMID:34834438. IF:3.508(Q2/4D).

Nomah, DK, Reyes-Uruena, J, Diaz, Y, Moreno, S, Aceiton, J, Bruguera, A, Vivanco-Hidalgo, RM, Llibre, JM, Domingo, P, Falco, V, Imaz, A, Cortes, C, Force, L, Letang, E, Vilaro, I, Casabona, J, Miro, JM, Mur I., Macorigh, Lizza. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021; 8(11)DOI:10.1016/S2352-3018(21)00240-X. PMID:34655549. IF:16.070(Q1/1D).

Kowalska, JD, Pelchen-Matthews, A, Ryom, L, Losso, MH, Trofimova, T, Mitsura, VM, Khromova, I, Paduta, D, Stephan, C, Domingo, P, Bakowska, E, Monforte, AD, Oestergaard, L, Jablonowska, E, Kuznetsova, A, Moreno, S, Vasylyev, M, Pradier, C, Battegay, M, Vandekerckhove, L, Castagna, A, Raben, D, Mocroft, A, EuroSIDA Study Grp. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period. AIDS. 2021; 35(12)DOI:10.1097/QAD.0000000000002954. PMID:34033590. IF:4.632(Q2/5D).

Arroyo-Diaz, JA, Julve, J, Vlacho, B, Corcoy, R, Ponte, P, Roman, E, Navas-Mendez, E, Llaurado, G, Franch-Nadal, J, Domingo, P, Mauricio, D. Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study. Frontiers in Public Health. 2021; 9DOI:10.3389/fpubh.2021.758347. PMID:34631653. IF:6.461(Q1/2D).

Teira, R, Diaz-Cuervo, H, Aragao, F, Munoz, J, Galindo, P, Merino, M, de la Fuente, B, Sepulveda, MA, Domingo, P, Garcia, J, Castano, M, Ribera, E, Geijo, P, Romero, A, Peraire, J, Deig, E, Roca, B, Martinez, E, Estrada, V, Montero, M, Berenguer, J, Espinosa, N. eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort. HIV Research & Clinical Practice. 2021; 22(3)DOI:10.1080/25787489.2021.1955197. PMID:34410219. IF:1.676(Q4/9D).

Gonzalez-Cordon, A, Assoumou, L, Moyle, G, Waters, L, Johnson, M, Domingo, P, Fox, J, Stellbrink, HJ, Guaraldi, G, Masia, M, Gompels, M, De Wit, S, Florence, E, Esser, S, Raffi, F, Behrens, G, Pozniak, A, Gatell, JM, Martinez, E. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(9)DOI:10.1093/jac/dkab158. PMID:34120186. IF:5.758(Q1/2D).

Palacio-Vieira, J, Reyes-Uruena, JM, Imaz, A, Bruguera, A, Force, L, Llaveria, AO, Llibre, JM, Vilaro, I, Borras, FH, Falco, V, Riera, M, Domingo, P, de Lazzari, E, Miro, JM, Casabona, J, Gurgui M., Hernandez, J.. Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review. BMC PUBLIC HEALTH. 2021; 21(1)DOI:10.1186/s12889-021-11613-y. PMID:34454444. IF:4.135(Q2/4D).

Rojas, J, de Lazzari, E, Negredo, E, Domingo, P, Tiraboschi, J, Ribera, E, Abdulghani, N, Puig, J, Mateo, MG, Podzamczer, D, Gutierrez, MM, Paredes, R, Clotet, B, Gatell, JM, Blanco, JL, Martinez, E, DOLAM Study Grp. Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial. Lancet HIV. 2021; 8(8)DOI:10.1016/S2352-3018(21)00100-4. PMID:34358497. IF:16.070(Q1/1D).

Domingo, P, Pomar, V, Mur, I, Castellvi, I, Corominas, H, de Benito, N. Not all COVID-19 pandemic waves are alike. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(7)DOI:10.1016/j.cmi.2021.04.005. PMID:33887469. IF:13.310(Q1/1D).

Domingo, P, Giralt, M, Gavalda-Navarro, A, Blasco-Roset, A, Delgado-Angles, A, Gallego-Escuredo, JM, Gutierrez, MD, Mateo, MG, Cereijo, R, Domingo, JC, Villarroya, F, Villarroya, J. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy. Adipocyte. 2022; 11(1)DOI:10.1080/21623945.2022.2042962. PMID:35300561. IF:3.300(Q3/6D).

Llaurado, G, Vlacho, B, Wargny, M, Ruan, Y, Franch-Nadal, J, Domingo, P, Gourdy, P, Saulnier, PJ, Hadjadj, S, Wild, SH, Rea, R, Cariou, B, Khunti, K, Mauricio, D. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19). Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01657-8. PMID:36261811. IF:9.300(Q1/1D).

Spinner, CD, Felizarta, F, Rizzardini, G, Philibert, P, Mitha, E, Domingo, P, Stephan, CJ, DeGrosky, M, Bainbridge, V, Zhan, J, Dumitrescu, TP, Jeffrey, JL, Xu, JF, Halliday, F, Gan, JJ, Johnson, M, Gartland, M, Joshi, SR, Lataillade, M. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. CLINICAL INFECTIOUS DISEASES. 2022; 75(5)DOI:10.1093/cid/ciab1065. PMID:34996113. IF:11.800(Q1/1D).

Castellvi, I, Castillo, D, Corominas, H, Mariscal, A, Orozco, S, Benito, N, Pomar, V, Baucells, A, Mur, I, de la Rosa-Carrillo, D, Lobo, D, Millan, AM, de Sosa, NH, Filella, D, Matas, L, Martinez-Martinez, L, Juarez, C, Casademont, J, Domingo, P. Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.973918. PMID:36004366. IF:3.900(Q2/4D).

Masip, J, Jorba, R, Lopez-Dupla, M, Domingo, P, Pacheco, YM, Garcia-Pardo, G, Martinez, E, Vilades, C, Veloso, S, Alba, V, Olona, M, Vidal, F, Gomez-Bertomeu, F, Peraire, J, Rull, A. Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(15)DOI:10.3390/ijms23158071. PMID:35897644. IF:5.600(Q1/3D).

Nomah, DK, Reyes-Uruena, J, Diaz, Y, Moreno, S, Aceiton, J, Bruguera, A, Vivanco-Hidalgo, RM, Casabona, J, Domingo, P, Navarro, J, Imaz, A, Deig, E, Navarro, G, Llibre, JM, Miro, JM. Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(8)DOI:10.1093/jac/dkac177. PMID:35678461. IF:5.200(Q1/3D).

Franquet, T, Gimenez, A, Ketai, L, Mazzini, S, Rial, A, Pomar, V, Domingo, P. Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT. EUROPEAN RADIOLOGY. 2022; 32(7)DOI:10.1007/s00330-022-08580-2. PMID:35226158. IF:5.900(Q1/2D).

Saumoy, M, Sanchez-Quesada, JL, Assoumou, L, Gatell, JM, Gonzalez-Cordon, A, Guaraldi, G, Domingo, P, Giacomelli, A, Connault, J, Katlama, C, Masia, M, Ordonez-Llanos, J, Pozniak, A, Martinez, E, Podzamczer, D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7)DOI:10.1093/jac/dkac117. PMID:35411401. IF:5.200(Q1/3D).

Moga, E, Lynton-Pons, E, Domingo, P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.904686. PMID:35833134. IF:7.300(Q1/3D).

Franquet, T, Domingo, P. Pulmonary Infections in People Living with HIV. RADIOLOGIC CLINICS OF NORTH AMERICA. 2022; 60(3)DOI:10.1016/j.rcl.2022.01.008. PMID:35534134. IF:1.900(Q3/8D).

Podzamczer, D, Mican, R, Tiraboschi, J, Portilla, J, Domingo, P, Llibre, JM, Ribera, E, Vivancos, MJ, Morano, L, Masia, M, Gomez, C, Fanjul, F, Payeras, A, Inciarte, A, Estrada, V, Rivero, A, Castro, A, Bernal, E, Vinuesa, D, Knobel, H, Troya, J, Macias, J, Montero, M, Sanz, J, Navarro-Alcaraz, A, Caicedo, A, Fernandez, G, Martinez, E, Moreno, S. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infectious Diseases. 2022; 9(3)DOI:10.1093/ofid/ofab595. PMID:35237700. IF:4.200(Q2/4D).